0460.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 11:08):

Stats
Šios dienos apimtis	16.35M
Vidutinė apimtis	7.60M
Rinkos kapitalizacija	5.20B
EPS	HKD0 ( 2024-03-27 )
Last Dividend	HKD0.0370 ( 2023-06-06 )
Next Dividend	HKD0 ( N/A )
P/E	-56.00
ATR14	HKD0.00100 (0.18%)

Tūris Koreliacija

Ilgas: 0.02 (neutral)

Trumpas: 0.00 (neutral)

Signal:(36.365) Neutral

Sihuan Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Sihuan Pharmaceutical Koreliacija - Valiuta/Žaliavos

0.57
( weak )

0.67
( moderate )

0.00
( neutral )

-0.55
( weak negative )

Sihuan Pharmaceutical Finansinės ataskaitos

Annual	2023
Pajamos:	HKD1.86B
Bruto pelnas:	HKD1.30B (69.64 %)
EPS:	HKD-0.00580

FY	2023
Pajamos:	HKD1.86B
Bruto pelnas:	HKD1.30B (69.64 %)
EPS:	HKD-0.00580

FY	2022
Pajamos:	HKD2.18B
Bruto pelnas:	HKD1.49B (68.20 %)
EPS:	HKD-0.210

FY	2021
Pajamos:	HKD3.29B
Bruto pelnas:	HKD2.45B (74.39 %)
EPS:	HKD0.0440

Financial Reports:

No articles found.

Sihuan Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0360 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0370 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Sihuan Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.27 - low (8.85%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0390	2011-09-21
Last Dividend	HKD0.0370	2023-06-06
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	HKD0.764	--
Avg. Dividend % Per Year	0.00%	--
Score	1.03	--
Div. Sustainability Score	3.27
Div.Growth Potential Score	0
Div. Directional Score	0.991	--

Next Divdend (Est)
(2024-10-25)

HKD0.0364 Estimate 3.62 %

Dividend Stability

0.29 Very Poor

Dividend Score

1.03

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2362.HK	No Dividend Player	2023-06-01	Annually	0.00%
1349.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0393.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
6677.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
1899.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
0927.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
2883.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
1480.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
0551.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0290	1.500	-0.581	-0.871	[0 - 0.5]
returnOnAssetsTTM	-0.00468	1.200	-0.156	-0.187	[0 - 0.3]
returnOnEquityTTM	-0.0122	1.500	-1.247	-1.870	[0.1 - 1]
payoutRatioTTM	-5.53	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.511	0.800	7.45	5.96	[1 - 3]
quickRatioTTM	1.160	0.800	7.88	6.30	[0.8 - 2.5]
cashRatioTTM	0.920	1.500	6.00	9.00	[0.2 - 2]
debtRatioTTM	0.106	-1.500	8.23	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.00318	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.00510	2.00	-0.00255	-0.00510	[0 - 20]
debtEquityRatioTTM	0.277	-1.500	8.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.696	1.000	1.727	1.727	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0736	1.000	-3.47	-3.47	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0231	1.000	-0.983	-0.983	[0.2 - 2]
assetTurnoverTTM	0.161	0.800	-2.26	-1.806	[0.5 - 2]
Total Score				3.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-85.44	1.000	-8.73	0	[1 - 100]
returnOnEquityTTM	-0.0122	2.50	-0.802	-1.870	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00510	2.00	-0.00170	-0.00510	[0 - 30]
dividendYielPercentageTTM	7.14	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00318	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	-5.53	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-0.934	1.500	-9.56	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0152	1.000	-2.12	0	[0.1 - 0.5]
Total Score				-1.286

Sihuan Pharmaceutical

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.